# Study on the Safety and Efficacy of Bimiralisib Gel in Participants Suffering From Actinic Keratosis

> **NCT06319794** · PHASE2 · COMPLETED · sponsor: **TORQUR** · enrollment: 46 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** Bimiralisib
- **DRUG:** Bimiralisib

## Key facts

- **NCT ID:** NCT06319794
- **Lead sponsor:** TORQUR
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-02
- **Primary completion:** 2025-06-24
- **Final completion:** 2025-06-24
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2025-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06319794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06319794, "Study on the Safety and Efficacy of Bimiralisib Gel in Participants Suffering From Actinic Keratosis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06319794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*